Perelman School of Medicine: PARP Inhibitor Drugs Can Be 'Tuned' for Better Killing of Tumor Cells
April 04, 2020
April 04, 2020
UNIVERSITY CITY, Pennsylvania, April 4 [TNSmedicalresearch] -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
A prospective "PARP inhibitor" drug that has struggled to show effectiveness in clinical trials against cancers can be structurally modified to greatly increase its power to kill tumor cells, researchers from Penn Medicine report this week in Science.
The team also showed that PARP inhibitor compounds ca . . .
A prospective "PARP inhibitor" drug that has struggled to show effectiveness in clinical trials against cancers can be structurally modified to greatly increase its power to kill tumor cells, researchers from Penn Medicine report this week in Science.
The team also showed that PARP inhibitor compounds ca . . .